News

The company's customer wins this year suggest more revenue expansion to come. In fact, C3.ai forecasts fiscal 2026 sales to ...
Upgrade your portfolio! C3.ai is a strong buy with explosive growth, top-tier partnerships, and AI exposure at a discount.
C3.Ai Inc AI shares are falling Thursday after the company announced a planned CEO transition. What To Know: C3.ai said it ...
C3.ai, Inc. (AI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...
Software company C3.ai Inc. is looking for a new chief executive officer after Tom Siebel said he intends to step aside due ...
We've waited quite some time for a reasonable choice of affordable small electric cars, and while they’re not exactly coming ...
Founded in 2009 by Thomas Siebel, C3.ai's core purpose has always been to deliver AI solutions to enterprises. Its value ...
C3 AI founder and Chief Executive Officer Tom Siebel today announced that he will step down because of health issues.
The U.S. Food and Drug Administration has approved Apellis Pharmaceuticals' Empaveli (pegcetacoplan) as the first treatment ...
C3.ai announced today that CEO Tom Siebel would be stepping down and that the company was in the process of looking for its ...
C3 AI's CEO search boosts M&A prospects as the company focuses on AI, big data & cloud. Discover why analysts see it as a ...